Gastroparesis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been experiencing nausea for more than 2 months
- People who are 18 years of age or older
- People who are able to understand English
- People who are currently receiving care at The Ohio State University
- People who are able to complete online surveys using a smartphone or computer
Who may not be able to join:
- People who are currently undergoing treatment for cancer
- People who are currently being treated for inflammatory bowel disease
- People who have cirrhosis (serious liver scarring)
- People who have end-stage renal (kidney) disease
- People who have previously used a wearable TENS device (a small electrical stimulation device worn on the body) for nausea
- People who have had abdominal surgery within the last 3 months
- People who are pregnant (as reported by the individual at the time of enrollment)
- People who currently have carpal tunnel syndrome (a nerve condition affecting the wrist and hand)
- People for whom the EmeTerm wrist device would not be medically appropriate to use (confirm with trial site)
- People who have skin problems near the wrist where the device would be worn, such as inflammation, irritation, infection, sores, bleeding, or open wounds
- People who have any metallic implants in their body
- People who have had a head or facial injury within the last 3 months
- People who have a known brain tumor, meningitis, or have had a stroke within the last 3 months
- People who have a cardiac pacemaker, an implanted defibrillator, or any other implanted metallic or electronic device
- People who have a history of seizures
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Subhankar CHAKRABORTY, MD, Ph.D., Ohio State University
Phone: 614-293-6255'
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Average Weekly Frequency of Moderate to Severe Nausea
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.